These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33813606)

  • 21. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study.
    Nors J; Iversen LH; Erichsen R; Gotschalck KA; Andersen CL
    JAMA Oncol; 2024 Jan; 10(1):54-62. PubMed ID: 37971197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
    Tokodai K; Narimatsu H; Nishida A; Takaya K; Hara Y; Kawagishi N; Hashizume E; Ohuchi N
    J Surg Oncol; 2016 Sep; 114(3):368-74. PubMed ID: 27264681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer.
    Osterman E; Hammarström K; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Acta Oncol; 2021 Jul; 60(7):842-849. PubMed ID: 33689551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competing risks analysis of the effect of local residual tumour on recurrence and cancer-specific death after resection of colorectal cancer: implications for staging.
    Newland RC; Chan C; Chapuis PH; Keshava A; Rickard MJFX; Young CJ; Dent OF
    Pathology; 2018 Oct; 50(6):600-606. PubMed ID: 30149993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for recurrence in colorectal cancer: a retrospective analysis in a regional Australian hospital.
    Holt J; Schwalb H; Elbourne H; Te Marvelde L; Reid C
    ANZ J Surg; 2021 Nov; 91(11):2482-2486. PubMed ID: 34595825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncologic long-term outcomes of emergency versus elective resection for colorectal cancer.
    Lavanchy JL; Vaisnora L; Haltmeier T; Zlobec I; Brügger LE; Candinas D; Schnüriger B
    Int J Colorectal Dis; 2019 Dec; 34(12):2091-2099. PubMed ID: 31709491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection.
    Kim C; Kim WR; Kim KY; Chon HJ; Beom SH; Kim H; Jung M; Shin SJ; Kim NK; Ahn JB
    Clin Colorectal Cancer; 2018 Sep; 17(3):e513-e518. PubMed ID: 29661621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
    Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
    Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hazard function analysis of metastatic recurrence after colorectal cancer surgery-A nationwide retrospective study.
    Ishimaru K; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Ishii H; Anzai H; Sonoda H; Yamauchi S; Sugihara K; Ishihara S;
    J Surg Oncol; 2021 Mar; 123(4):1015-1022. PubMed ID: 33444465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of high-risk stage I colon and rectal cancer patients: a retrospective analysis of a large Japanese cohort.
    Fukui Y; Hida K; Hoshino N; Nishizaki D; Okamura R; Yamauchi S; Sugihara K; Sakai Y;
    Int J Colorectal Dis; 2022 Jun; 37(6):1403-1410. PubMed ID: 35588331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for postoperative recurrence in patients with stage II colorectal cancer.
    Xiong ZZ; Xie MH; Li XZ; Jin LY; Zhang FX; Yin S; Chen HX; Lian L
    BMC Cancer; 2023 Jul; 23(1):658. PubMed ID: 37452325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
    Suthananthan AE; Bhandari M; Platell C
    ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study.
    Holmes AC; Riis AH; Erichsen R; Fedirko V; Ostenfeld EB; Vyberg M; Thorlacius-Ussing O; Lash TL
    Acta Oncol; 2017 Aug; 56(8):1111-1119. PubMed ID: 28339306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cumulative incidence of first recurrence after curative treatment of stage I-III colorectal cancer. Competing risk analyses of temporal and anatomic patterns.
    Storli PE; Dille-Amdam RG; Skjærseth GH; Gran MV; Myklebust TÅ; Grønbech JE; Bringeland EA
    Acta Oncol; 2023 Dec; 62(12):1822-1830. PubMed ID: 37862319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients.
    Yang J; Du XL; Li ST; Wang BY; Wu YY; Chen ZL; Lv M; Shen YW; Wang X; Dong DF; Li D; Wang F; Li EX; Yi M; Yang J
    PLoS One; 2016; 11(12):e0167540. PubMed ID: 27936129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
    Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
    Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right colon, left colon, and rectal cancer have different oncologic and quality of life outcomes.
    Duraes LC; Steele SR; Valente MA; Lavryk OA; Connelly TM; Kessler H
    Int J Colorectal Dis; 2022 Apr; 37(4):939-948. PubMed ID: 35312830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.